Excess quantities of a specific protein in the brain dramatically increase the chances of so-called “nucleation events” that could eventually result in Parkinson’s Disease, according to a new study.
Research will make the study of diseases such as Parkinson’s and Alzheimer’s easier, and could lead to personalised therapies for a variety of neurodegenerative disorders.
What do physicists, chemists, mathematicians and biologists have in common? One of the answers at Cambridge is a shared interest in unravelling the processes behind neurodegenerative diseases such as Alzheimer's, Parkinson's and Motor Neurone Disease.
A collaboration between virologists and neuroscientists at Cambridge University has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson’s and other neurodegenerative diseases.
New treatments for glaucoma are a key priority in vision research. Advances in stem cell technology in Cambridge are helping to make this dream a reality.
The way a common virus hijacks the cell it infects could hold the clue to combating Parkinson's disease.
Cambridge neurologists have shown that an antibody used to treat leukaemia also limits and repairs the damage in multiple sclerosis.
© 2025 University of Cambridge